Sigachi Indust. (SIGACHI)

FairStock Score: 43/100 — MIXED

Score breakdown: P/E: 2/3 · ROCE: 1/2 · Growth: 0/2 · Dividend: 0/1

Key Financials

Strengths

• Debt/equity is low at 0.32, so the balance sheet is not highly leveraged.
• ROCE of 15.54% suggests the underlying operating assets still generate positive returns.
• Book value of ₹11.74 gives some asset backing; P/B of 1.91 is not extreme.
• Trading closer to the 52-week low of ₹16.65 than the high of ₹46.73, reflecting a de-rated stock.

Concerns

• ROE is deeply negative at -17.28% with latest quarterly net profit near ₹0 Cr, indicating shareholder-level losses.
• Sales growth is -15.93% and profit growth is -96.49%, showing severe business deterioration.
• Piotroski F-Score of 3/9 points to weak fundamentals across profitability and financial health.
• A P/E of 19.21 on collapsing earnings is not cheap and could be a value trap.

AI Analysis

When I look at Sigachi, I see a business that fails Graham's first test: a consistent earnings record. The numbers here are loud warning bells. Sales have fallen nearly 16%, and profit growth has collapsed by more than 96% — from an already modest base to almost nothing. The latest quarter reports net profit of roughly ₹0 Cr on ₹117 Cr of sales, which tells me the margin structure has broken down. A negative ROE of -17.28% means shareholder capital is shrinking, despite a positive ROCE of 15.54%. That gap suggests operating assets still earn something, but the equity returns are being destroyed somewhere in the capital structure or by non-operating items. In Buffett's language, the economic moat is missing or under serious attack. The balance sheet is not terrible: debt/equity is only 0.32, and book value is ₹11.74 against a price of ₹22.48. But a P/B of 1.91 is not a bargain when returns on equity are negative. The so-called earnings multiple of 19.21 is misleading when profits have plunged; a low P/E on falling earnings can be a value trap, not an opportunity. The Piotroski score of 3/9 reinforces the poor fundamental health. Promoter holding at 39.70% is not reassuring enough to offset these operational red flags. I would not classify this as a stalwart or a grower. It is a possible turnaround, but only if sales stabilise, margins recover, and ROE turns decisively positive. Until then, the prudent approach is to watch from the sidelines. Graham taught us to buy with a margin of safety; here the safety is absent. A 10/100 risk score from FairStock agrees. I need evidence of real improvement before I put a rupee into Sigachi.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer